[go: up one dir, main page]

RU2006114078A - MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF RHEUMATIC DISEASES - Google Patents

MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF RHEUMATIC DISEASES Download PDF

Info

Publication number
RU2006114078A
RU2006114078A RU2006114078/15A RU2006114078A RU2006114078A RU 2006114078 A RU2006114078 A RU 2006114078A RU 2006114078/15 A RU2006114078/15 A RU 2006114078/15A RU 2006114078 A RU2006114078 A RU 2006114078A RU 2006114078 A RU2006114078 A RU 2006114078A
Authority
RU
Russia
Prior art keywords
phospholipids
rheumatic diseases
treatment
salt
glycyrrhizic acid
Prior art date
Application number
RU2006114078/15A
Other languages
Russian (ru)
Other versions
RU2330664C2 (en
Inventor
Александр Иванович Арчаков (RU)
Александр Иванович Арчаков
Ольга Михайловна Ипатова (RU)
Ольга Михайловна Ипатова
Мари Геннадьевна Зыкова (RU)
Мария Геннадьевна Зыкова
Владимир Николаевич Прозоровский (RU)
Владимир Николаевич Прозоровский
Мари Кирилловна Гусева (RU)
Мария Кирилловна Гусева
Елена Георгиевна Тихонова (RU)
Елена Георгиевна Тихонова
Евгений Львович Насонов (RU)
Евгений Львович Насонов
Тать на Викторовна Коротаева (RU)
Татьяна Викторовна Коротаева
Original Assignee
Александр Иванович Арчаков (RU)
Александр Иванович Арчаков
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Александр Иванович Арчаков (RU), Александр Иванович Арчаков filed Critical Александр Иванович Арчаков (RU)
Priority to RU2006114078/15A priority Critical patent/RU2330664C2/en
Publication of RU2006114078A publication Critical patent/RU2006114078A/en
Application granted granted Critical
Publication of RU2330664C2 publication Critical patent/RU2330664C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (4)

1. Лекарственный препарат для внутрисуставного введения при лечении ревматических заболеваний, включающий 0,1-3,0 мас.% метотрексата фиксированного на фосфолипидных наночастицах, причем наночастицы состоят из фосфолипидов, глицирризиновой кислоты или ее соли и вспомогательных веществ при суммарном содержании фосфолипидов и глицирризиновой кислоты или ее соли 2-80 мас.% и массовом соотношении фосфолипидов и глицирризиновой кислоты или ее соли не более 4:1.1. A drug for intraarticular administration in the treatment of rheumatic diseases, comprising 0.1-3.0 wt.% Methotrexate fixed on phospholipid nanoparticles, and the nanoparticles are composed of phospholipids, glycyrrhizic acid or its salt and excipients with a total content of phospholipids and glycyrrhizic acid or its salt 2-80 wt.% and the mass ratio of phospholipids and glycyrrhizic acid or its salt is not more than 4: 1. 2. Препарат по п.1, отличающийся тем, что он включает в качестве фосфолипидов фосфатидилхолин растительного или животного происхождения.2. The drug according to claim 1, characterized in that it includes phosphatidylcholine of plant or animal origin as phospholipids. 3. Способ лечения ревматических заболеваний путем назначения пациенту, нуждающемуся в этом, внутрисуставных инъекций лекарственного препарата по п.1.3. A method of treating rheumatic diseases by administering to a patient in need of this, intra-articular injections of the drug according to claim 1. 4. Способ по п.3, отличающийся тем, что ревматическим заболеванием является ревматоидный артрит и псориатический артрит.4. The method according to claim 3, characterized in that the rheumatic disease is rheumatoid arthritis and psoriatic arthritis.
RU2006114078/15A 2006-04-26 2006-04-26 Medical product and method of rheumatic diseases treatment RU2330664C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2006114078/15A RU2330664C2 (en) 2006-04-26 2006-04-26 Medical product and method of rheumatic diseases treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006114078/15A RU2330664C2 (en) 2006-04-26 2006-04-26 Medical product and method of rheumatic diseases treatment

Publications (2)

Publication Number Publication Date
RU2006114078A true RU2006114078A (en) 2007-11-20
RU2330664C2 RU2330664C2 (en) 2008-08-10

Family

ID=38958973

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006114078/15A RU2330664C2 (en) 2006-04-26 2006-04-26 Medical product and method of rheumatic diseases treatment

Country Status (1)

Country Link
RU (1) RU2330664C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119950532A (en) * 2024-05-08 2025-05-09 北京中医药大学 A pharmaceutical composition for treating rheumatoid arthritis and its application

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2411942C2 (en) * 2009-05-05 2011-02-20 Общество с ограниченной ответственностью "ЭкоБиоФарм" Pharmaceutic composition including arbidol in composition of phospholipid nanoparticles
CN102716463A (en) * 2012-06-19 2012-10-10 北京中海康医药科技发展有限公司 Glycyrrhizic acid organic salt phospholipid ligand and preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA911974B (en) * 1990-03-21 1994-08-22 Res Dev Foundation Heterovesicular liposomes
RU2133122C1 (en) * 1998-10-14 1999-07-20 Научно-исследовательский институт биомедицинской химии РАМН Composition exhibiting property for biological membrane repairing

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119950532A (en) * 2024-05-08 2025-05-09 北京中医药大学 A pharmaceutical composition for treating rheumatoid arthritis and its application

Also Published As

Publication number Publication date
RU2330664C2 (en) 2008-08-10

Similar Documents

Publication Publication Date Title
AU2023222925B2 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
ES2315417T3 (en) USES OF OLIGOSACARIDOS DE QUITOSANA.
EP1758603A1 (en) Treatment for asthma and arthritis and other inflammatory diseases
US20250099498A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
ATE513557T1 (en) METHOD FOR TREATING HUMAN DISEASES ASSOCIATED WITH INCREASED DEOXYRIBONUCLEIC ACID CONTENT IN EXTRACELLULAR SPACES OF TISSUES AND MEDICAL PREPARATION FOR CARRYING OUT THE METHOD
US20170157169A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
RU2006114078A (en) MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF RHEUMATIC DISEASES
CN115154465A (en) Use of compounds for treating pain and inflammation in degenerative joint disease in dogs
EP3017816A2 (en) Diindolylmethane-based medicinal agent and use thereof to treat influenza and viral respiratory infections
US20160113986A1 (en) Medicament for treating muscle and skeletal diseases
JP6100510B2 (en) Anti-cold medicine
JPWO2020009950A5 (en)
CN110917209A (en) Application of selenium-containing compound or selenium nano-grade in preparation of injection or microneedle of arthritis treatment drug
JP2021066724A (en) External pharmaceutical compositions for preventing and treating rheumatoid arthritis
RU2290922C1 (en) Agent for treatment of joint diseases
RU2292203C1 (en) Means for treating patients for articulation diseases
RU2282437C1 (en) Agent for treatment of joint disease
BRPI0902144A2 (en) process for preparing a solid oral administration pharmaceutical composition containing the active ingredients glycosamine and meloxicam and use of the association between glycosamine and meloxicam
CN101411700B (en) Use of 5,7,4'-trihydroxy flavanone or derivative thereof for analgesia
ES2425045T3 (en) Acetyl-L-carnitine for the prevention of painful peripheral diabetic neuropathy
CN108929358A (en) Arginine glycyrrhizin and its preparation method and application
US20160287627A1 (en) Method for suppressing onset of gastric ulcer as adverse effect of drug, oral pharmaceutical composition for suppressing onset of gastric ulcer and method for producing the same
ES2638195B1 (en) SKIN COMPOSITIONS
JP2018518453A (en) New use of isoquinoline derivatives for the treatment of diabetic wounds
RU2004128011A (en) MEDICINAL PRODUCT AND METHOD FOR HEALING HUMAN AND ANIMALS

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20160427